Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

NCT06868290 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

ANCA Associated Vasculitis (AAV)

Interventions

BIOLOGICAL: Rapcabtagene autoleucel
OTHER: Active Comparator
DRUG: Glucocorticoids

Sponsor

Novartis Pharmaceuticals